GSK

GSK buys asthma drug developer for up to $1.4 bn

Credit: Pixabay/CC0 Public Domain British drugmaker GlaxoSmithKline on Tuesday agreed to buy Aiolos Bio for up to $1.4 billion, with…

6 months ago

This website uses cookies.